Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design.
作者： Roberto Coccurello , Anna Moles
DOI: 10.1016/J.PHARMTHERA.2010.04.008
关键词:
摘要: … in the analysis of the potential mechanisms underlying the … be viewed as potent obesogenic factors that can be exploited as … identified obesogenic and diabetogenic mechanisms are the …
core.ac.uk
cabdirect.org
cnr.it
elsevier.com
sci-hub.se 参考文章(480)
Pavlos Pissios, Lauren Frank, Adam R. Kennedy, Douglas R. Porter, Francis E. Marino, Fen-Fen Liu, Emmanuel N. Pothos, Eleftheria Maratos-Flier, Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice Biological Psychiatry. ,vol. 64, pp. 184- 191 ,(2008) , 10.1016/J.BIOPSYCH.2007.12.011
Michael Poyurovsky, Ilanit Isaacs, Camil Fuchs, Michael Schneidman, Sarit Faragian, Ronit Weizman, Abraham Weizman, Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study American Journal of Psychiatry. ,vol. 160, pp. 297- 302 ,(2003) , 10.1176/APPI.AJP.160.2.297
Lee G. D. Fryer, Asha Parbu-Patel, David Carling, The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways Journal of Biological Chemistry. ,vol. 277, pp. 25226- 25232 ,(2002) , 10.1074/JBC.M202489200
Mikhail Kalinichev, Claire Rourke, Declan N.C. Jones, Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine Behavioural Pharmacology. ,vol. 17, pp. 289- 292 ,(2006) , 10.1097/00008877-200605000-00009
Mark Olfson, Steven C. Marcus, Patricia Corey-Lisle, A.V. Tuomari, Patricia Hines, Gilbert J. L’Italien, Hyperlipidemia Following Treatment With Antipsychotic Medications American Journal of Psychiatry. ,vol. 163, pp. 1821- 1825 ,(2006) , 10.1176/AJP.2006.163.10.1821
Frank P Bymaster, David O Calligaro, Julie F Falcone, Richard D Marsh, Nicholas A Moore, Nicholas C Tye, Philip Seeman, David T Wong, Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology. ,vol. 14, pp. 87- 96 ,(1996) , 10.1016/0893-133X(94)00129-N
M B Cope, T R Nagy, J R Fernández, N Geary, D E Casey, D B Allison, Antipsychotic drug-induced weight gain: development of an animal model International Journal of Obesity. ,vol. 29, pp. 607- 614 ,(2005) , 10.1038/SJ.IJO.0802928
ANDRÉS MARTIN, JEFFREY LANDAU, PATRICIA LEEBENS, KARA ULIZIO, DOMENIC CICCHETTI, LAWRENCE SCAHILL, JAMES F. LECKMAN, Risperidone-associated weight gain in children and adolescents: a retrospective chart review. Journal of Child and Adolescent Psychopharmacology. ,vol. 10, pp. 259- 268 ,(2000) , 10.1089/CAP.2000.10.259
Jonathan M. Meyer, A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 year The Journal of Clinical Psychiatry. ,vol. 63, pp. 425- 433 ,(2002) , 10.4088/JCP.V63N0509
N. Stefan, M. Stumvoll, Adiponectin - Its Role in Metabolism and Beyond Hormone and Metabolic Research. ,vol. 34, pp. 469- 474 ,(2002) , 10.1055/S-2002-34785